鹏华国证港股通创新药ETF开启认购
Zheng Quan Shi Bao Wang·2025-08-11 02:34
Group 1 - The Penghua Guozheng Hong Kong Stock Connect Innovative Drug ETF (159286) will be available for subscription from August 11 to August 15, 2025, with a maximum initial fundraising scale of 2 billion yuan [1] - The fund will be managed by Penghua Fund, with Lin Song and Zhang Yuxiang serving as fund managers [1] - The performance benchmark for the fund is the return rate of the Guozheng Hong Kong Stock Connect Innovative Drug Index (adjusted for exchange rates) [2]